McCollum Christoferson Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.55M Sell
43,633
-8
-0% -$1.75K 2.84% 12
2025
Q1
$9.77M Buy
43,641
+447
+1% +$100K 2.98% 10
2024
Q4
$14.1M Buy
43,194
+14
+0% +$4.59K 4.18% 4
2024
Q3
$13M Sell
43,180
-474
-1% -$142K 3.75% 6
2024
Q2
$14.4M Sell
43,654
-1,699
-4% -$560K 4.28% 4
2024
Q1
$17.9M Sell
45,353
-323
-0.7% -$128K 5.19% 2
2023
Q4
$16.1M Sell
45,676
-578
-1% -$204K 4.87% 3
2023
Q3
$17.4M Sell
46,254
-1,686
-4% -$633K 5.33% 2
2023
Q2
$18.3M Sell
47,940
-1,060
-2% -$405K 5.22% 2
2023
Q1
$17M Sell
49,000
-980
-2% -$340K 5.23% 2
2022
Q4
$11.8M Buy
49,980
+271
+0.5% +$63.8K 3.72% 5
2022
Q3
$12.2M Sell
49,709
-80
-0.2% -$19.7K 4.09% 3
2022
Q2
$15.1M Sell
49,789
-392
-0.8% -$119K 4.59% 2
2022
Q1
$20.6M Sell
50,181
-686
-1% -$282K 5.09% 1
2021
Q4
$23.9M Sell
50,867
-856
-2% -$401K 5.37% 1
2021
Q3
$22M Sell
51,723
-2,655
-5% -$1.13M 5.23% 1
2021
Q2
$19.5M Sell
54,378
-2,160
-4% -$776K 4.64% 1
2021
Q1
$15.9M Sell
56,538
-2,330
-4% -$657K 4.05% 1
2020
Q4
$16.7M Sell
58,868
-2,539
-4% -$719K 4.27% 2
2020
Q3
$16.9M Sell
61,407
-2,477
-4% -$681K 4.85% 2
2020
Q2
$14.5M Sell
63,884
-2,215
-3% -$503K 4.71% 1
2020
Q1
$10.1M Sell
66,099
-2,695
-4% -$410K 4.02% 1
2019
Q4
$10.3M Sell
68,794
-1,615
-2% -$243K 3.48% 2
2019
Q3
$10M Sell
70,409
-1,724
-2% -$245K 3.57% 1
2019
Q2
$9.03M Sell
72,133
-649
-0.9% -$81.2K 3.18% 3
2019
Q1
$8.02M Sell
72,782
-342
-0.5% -$37.7K 2.96% 3
2018
Q4
$7.17M Buy
73,124
+405
+0.6% +$39.7K 3.03% 2
2018
Q3
$8.98M Sell
72,719
-494
-0.7% -$61K 3.29% 2
2018
Q2
$7.27M Sell
73,213
-190
-0.3% -$18.9K 2.96% 4
2018
Q1
$6.48M Sell
73,403
-4,128
-5% -$364K 2.7% 7
2017
Q4
$7.65M Buy
+77,531
New +$7.65M 3.17% 3